This inventor holds 1 USPTO granted patent. Top assignee: Kanghong USA, Inc.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Jinsong Yang: Innovator in Cancer Drug Development
Introduction
Jinsong Yang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of drug development, particularly in the area of cancer treatment. His innovative work focuses on overcoming multi-drug resistance in chemotherapy.
Latest Patents
Jinsong Yang holds a patent for the "Preparation and drug composition of bis-benzyl-isoquinoline class alkaloids." This invention pertains to the preparation of bis-isoquinoline derivatives, which possess multi-drug resistance (MDR) reversal activities. The drug compositions and formulations he developed are designed to enhance sensitivity in cancer chemotherapy. Additionally, methods for inhibiting MDR through treatment with these bis-isoquinoline derivatives are also provided in his patent.
Career Highlights
Jinsong Yang is associated with Kanghong USA, Inc., where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments for cancer patients facing challenges with drug resistance.
Collaborations
He has collaborated with notable colleagues, including Donglin Chen and Xixian Jian, to further enhance the impact of his research in the pharmaceutical field.
Conclusion
Jinsong Yang's innovative contributions to cancer drug development highlight his commitment to improving treatment options for patients. His work in overcoming multi-drug resistance is a significant step forward in the fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile